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A culture of mouse cells containing a 1,000-nucleotide deletion mutant of
Moloney murine leukemia virus has been isolated. The deletion did not affect the
size or function of the 21S mRNA that encodes the env gene products. Both the
deleted RNA and the 21S mRNA were recovered in polyribosomes. Cells con-
taining the deleted virus made no detectable Pr1809'". Pr659'9 synthesis was
also absent, but a 45,000-molecular-weight gag gene product was found that
might be encoded by the deleted genome. Biosynthesis of Pr80env proceeded
normally in these cells; the intracellular precursor was cleaved and migrated to
the cell surface as gp7O. The cells could not be superinfected by homologous
Moloney murine leukemia virus presumably because of surface restriction due to
the gp7O. Although the cells express the Moloney murine leukemia virus gp7O on
their surface, they will not make pseudotypes after infection with vesicular
stomatitis virus implying that Pr659'9 may play a critical role in pseudotype
formation. Induction of endogenous virus expression in the cells carrying the
deletion mutant generated an N-tropic murine leukemia virus that can fuse XC
cells. This may represent a recombinant between the deletion mutant and an
endogenous virus.
Although infections ofmouse cells by a murine
leukemia virus (MuLV) are usually thought to
result in a virus-producing infected cell, there
are reports of nonproductive cells that produce
viral antigens and were therefore infected (42,
47). Such a state is also seen in cultured normal
cells from certain mouse strains and reflects
expression of endogenous viral genomes; in fact,
most mouse cells express some viral antigen but
make no virus (6, 32, 38, 51).
__-
A few years ago we noted that a culture of
cells infected with Moloney MuLV (M-MuLV)
was producing decreasing yields of virus with
continuous passage. We have recovered from
that culture a nonproducer cell line that ex-
presses viral glycoprotein but little of the other
viral proteins. Cells productively infected with
M-MuLV make gene products from the three
known genetic regions of the M-MuLV genome:
gag (the internal virion proteins), pol (the re-
verse transcriptase), and env (the glycoprotein).
The nonproducer cell line isolated in these stud-
ies is infected with a deleted M-MuLV genome
that makes no normal gag or pol products but
has an apparently normal env gene product and
a normal env mRNA.
MATERIALS AND METHODS
Cells and leukemia viruses. Most of the cells and
viruses have been described previously. JLS-V11 cells
(58) were provided by Electronucleonics Inc., Be-
thesda, Md., 18 passages after their infection with M-
MuLV. JLS-V9 (V9) cells (58) were obtained from
Kenneth Manly (Roswell Park Memorial Institute).
NIH/3T3 cells (26) were a gift of S. A. Aaronson
(National Institutes of Health). BALB/3T3 cells clone
A31 (1) were obtained from R. Pollack, and the 8c
subclone 81 cat cells, a sarcoma-positive leukemia-
negative (S+L-) cat cell line transformed by Moloney
murine sarcoma virus (17), was kindly provided by P.
Fischinger. NIH/3T3 cells producing M-MuLV clone
1 virus were derived in this laboratory (16). XC cells
(52) were provided by J. Hartley (National Institutes
of Health). Cells were grown in Dulbecco-modified
Eagle medium with 10% calfserum (NIH/3T3, BALB/
3T3, XC, and NIH cells producing M-MuLV) or with
10% heat-inactivated fetal calf serum (JLS-V9, JLS-
Vli, and all subclones derived from JLS-V11). The
cat S+L- cells were grown in McCoy SA medium plus
14% heat-inactivated fetal calf serum.
M-MuLV infections and direct plaque assay.
Plaque assays were performed with the XC cell fusion
procedure (44). For quantitation of MuLVx (xeno-
tropic MuLV), the focus assay described by Fischinger
et al. (17) was used. Reverse transcriptase assays of
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supernatants were done as described elsewhere (20).
Infective center assays were carried out by a modi-
fication of a published procedure (26). Sensitive
BALB/3T3 cells were plated at 105 cells per 6-cm dish.
The next day, cells to be tested were trypsinized for 10
min with 0.5% trypsin at room temperature, diluted
into medium, and then plated onto the indicator cells
at various densities. After 3 days the cultures were UV
irradiated and overlaid with XC cells. The plating
efficiency of the cells was determined separately. JLS-
V9 and JLS-V11 routinely gave plating efficiencies of
60 to 80%.
Antisera. Fluorescein-conjugated antibody to
Tween-ether-disrupted M-MuLV made in goats and
rhodamine counter stain were obtained through the
Virus Cancer Program. Anti-Friend MuLV gp7O serum
made in rabbits was kindly provided by D. Bolognesi.
Goat anti-rabbit immunoglobulin and normal rabbit
serum were purchased from Meloy Laboratories. Anti-
MuLV p30 serum made in rabbits was kindly provided
by David Livingston. Anti-M-MuLV p30 and gp69/70
antisera made in rabbits were prepared in this labo-
ratory (39).
Radioimmunoassays. The cell extracts were pre-
pared as follows. Subconfluent plates of cells (15 cm)
were harvested with phosphate-buffered saline (PBS)
(pH 7.4)-2 mM EDTA and then washed three times
with PBS. Cells were stored as 20% cell packs at
-70°C. The cell packs were disrupted in 1% Triton X-
100 and 0.5% sodium deoxycholate, and the nuclei
were collected by centrifugation at 2,000 rpm for 4
min. The supernatant was then extracted twice with
ether, and the aqueous phase was dialyzed with 0.05
M Tris-hydrochloride (pH 7.8) and used for the ra-
dioimmunoassay. The radioimmunoprecipitation as-
says for the p30 protein were performed as described
by Parks et al. (38). Protein determinations were done
by the Lowry (31) method with bovine serum albumin
as a standard. The first incubation was carried out in
450 td of 0.1 M NaPO4, (pH 7.5), 1% normal rabbit
serum, 0.01% Triton X-100, 0.01 M EDTA, competing
antigen and rabbit anti-M-MuLV p30 for 1 h at 37°C,
and then 50 pl of '2I-p30 (10,000 cpm) in 0.1 M NaPO4(pH 7.5), 0.01% Triton X-100, 0.01 M EDTA, and 1%
normal rabbit serum was added and incubated for
another hour at 37°C. Finally, 30 ul of goat anti-rabbit
immunoglobin serum was added, and the mixture was
incubated for 1 h at 37°C. The precipitate was col-
lected by centrifugation for 10 min at 3,000 cpm. The
supematant was decanted, and the pellet was washed
with 0.5 ml of 1-mg/ml bovine serum albumin-0.1%
Nonidet P-40 in PBS. The precipitate was again col-
lected by centrifugation. This washing procedure was
repeated three times. The tubes were then counted in
a gamma-ray counter.
Immunofluorescence. Cytoplasmic staining was
carried out as described previously (20).
Membrane staining of live cells. The procedures
for staining antigens on the surface of live cells were
provided by Nancy Hopkins (unpublished data). Cover
slips with cells were washed five times in PBS con-
taining 1 mM CaCl2 and 0.5 mM MgCl2 (PBS-MC). A
25-,ul amount of a 1/40 dilution of fluorescein-conju-
gated anti-M-MuLV antibody and a 1/100 dilution of
rhodamine counterstain in PBS-MC was added, and
the cover slips were incubated for 30 min in a moist
chamber at 37°C. They were then washed five times
in PBS-MC and mounted onto slides with PBS-MC
and 50% glycerol.
For membrane staining of formaldehyde-fixed cells,
cover slips with cells were washed five times in PBS
and then fixed for 20 min in PBS containing 3.5%
formaldehyde at room temperature. The cover slips
were then washed five times in PBS and stained as
described in the procedure for acetone-fixed cells.
The method used for indirect staining with noncon-
jugated rabbit anti-glycoprotein antiserum was as fol-
lows. For membrane staining of live cells, cover slips
with cells were washed with PBS-MC, 25 pi of a 1/20
dilution of anti-glycoprotein rabbit antiserum in PBS-
MC were added, and incubation was carried out for 30
min at 37°C in a moist chamber. The cover slips were
then washed five times in PBS-MC, 25 ul of a 1/40
dilution of fluorescein-conjugated goat anti-rabbit an-
tiserum and a 1/100 dilution of rhodamine counter-
stain in PBS-MC was added, and the second incuba-
tion was carried out for 30 min at 37°C. The cover
slips were washed extensively and mounted as de-
scribed above. For cytoplasmic staining of acetone-
fixed cells and for membrane staining of formalde-
hyde-fixed cells, the procedure was modified accord-
ingly.
Metabolic labeling and gel electrophoresis.
Cultures about 70% confluent (10-cm plates) were
labeled for 2 h with [35S]methionine (New England
Nuclear Corp., 50,uCi/ml) in Dulbecco-modified Eagle
medium containing 1/50 the normal methionine con-
centration and 10% dialyzed heat-inactivated fetal calf
serum. The cells were lysed with 0.01 M phosphate
(pH 7.2), 1% Triton X-100, 0.5% sodium deoxycholate,
0.1% sodium dodecyl sulfate (SDS), and 0.15 M NaCl.
The lysates were scraped from the plates and clarified
by centrifugation for 10 min at 1,000 x g.
To reduce nonspecific background in the immuno-
precipitation, the lysates were precleared by the tech-
nique of Witte et al. (56). Extracts were incubated
overnight with 10 pl of normal rabbit serum at 4°C
and then for 1 h at 4°C with 100 pl of 10% (wt/vol)
Formalin-fixed Staphylococcus aureus as previously
described (28). The components bound to S. aureus
were collected by centrifugation for 30 min at 35,000
rpm in a Beckman ultracentrifuge.
The supernatants were then immunoprecipitated
by overnight incubation at 4°C with the appropriate
antiserum followed by 1 h of incubation with S. aureus
(as above). The precipitates were washed three times
with lysis buffer, resuspended in 50 ,ll of 50 mM Tris
(pH 6.8)-1% 2-mercaptoethanol-1% SDS-10% glyc-
erol-bromophenol blue, boiled for 5 min, and analyzed
on 5 to 20% gradient slab gels (29). The gels were
stained and dried, and the labeled bands were visual-
ized by fluorography and autoradiography at -70°C
(9).
Extraction and analysis of cytoplasmic RNA.
Cytoplasmic RNA from producer and nonproducer
cells was prepared as described previously (14) and by
the urea-SDS method (19) as described by Sharp et
al. (46). Polyadenylic acid-containing RNA was pre-
pared by affinity chromatography on oligodeoxythy-
midylic acid-cellulose (T3, Collaborative Research)
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(3). Cytoplasmic RNAs were analyzed in 15 to 30%
sucrose gradients containing 0.1% SDS as described
previously (14). Purified polyribosomes were prepared
as described previously by sedimenting polyribosomes
from cytoplasmic extracts through 1 and 2 M sucrose
(15, 18). Electrophoresis of RNA on denaturing meth-
ylmercuric hydroxide agarose gels was performed as
described by Bailey and Davidson (4) with a slab gel
apparatus (20 by 12 by 0.3 cm). Methylmercuric hy-
droxide was obtained from Alfa Products (Danvers,
Mass.) as a 1 M stock solution.
Preparation of M-MuLV cDNA and hybridiza-
tion techniques. 3H-labeled M-MuLV complemen-
tary (cDNA) was prepared by incubation of M-MuLV
clone 1 virions (16) in vitro in the endogenous RNA-
dependent DNA polymerase reaction, as described
previously (13). The specific activity of the M-MuLV
cDNA was 1.6 x 107 cpm/jug as calculated from the
specific activity of the radioactive deoxyribonucleoside
triphosphate precursor. 3H-labeled M-MuLV cDNA
that had been depleted of uninfected BALB/c cell
complementary sequences was a kind gift of Rudolf
Jaenisch, and its preparation is described by Jaenisch
(23).
32P-labeled M-MuLV cDNA was prepared from M-
MuLV grown in NRK cells (CP1 cells, E. Rothenberg,
unpublished data) according to Taylor et al. (53) in
the presence of calf thymus oligodeoxynucleotide
primers. The initial specific activity of the cDNA was
108 to 2 x 108 cpm/,ug as calculated from the specific
activity of the labeled precursor.
Hybridization of cytoplasmic RNAs with M-MuLV
cDNA to measure extent and concentration of virus-
specific RNA sequences was as previously described
(13). Briefly, the RNA samples were combined with
3H-labeled M-MuLV cDNA (500 to 1,000 cpm) and
incubated for the times indicated. Annealing condi-
tions were 0.3 M NETES (0.3 M NaCl, 0.01 M TES,
pH 7.5, 1 mM EDTA)-0.1% SDS at 66°C, and the
total reaction volume was 5 to 7 p1. After annealing,
the samples were expelled into 50 pl of S1 nuclease
reagent (40 U of S1 nuclease per ml, 0.25 M K acetate
[pH 4.5], 20 ,ug of denatured calf thymus DNA per ml,
0.01 M ZnSO4), and the unhybridized cDNA was di-
gested for 30 to 60 min at 45°C. The S1-resistant
matekial was precipitated with trichloroacetic acid,
and radioactivity in precipitated material was meas-
ured by filtration (Millipore Corp.) and liquid scintil-
lation counting.
Hybridization across sucrose gradients was per-
formed as described (13). Briefly, samples of sucrose
gradient fractions were adjusted to annealing condi-
tions and M-MuLV cDNA (500 to 1,000 cpm) was
added to each sample. After incubation of all of the
samples for the same length of time, the hybridized
cDNA was measured and converted to relative virus-
specific RNA concentration as described before (13).
Transfer of RNA from agarose gels to diazo-
benzyloxymethyl paper. The aminobenzyloxyme-
thyl paper was prepared from 1-[(m-nitrobenzyl-
oxy)methyl]pyridium chloride and stored in a desic-
cator at 5°C. Immediately before the transfer was
started the paper was diazotized at 4°C. The methyl-
mercuric hydroxide agarose gel was quenched with 0.5
M NH4Ac and stained with 10 ,ug of ethidium bromide
per ml. The gel was then placed into 200 ml of 50 mM
NaOH-5 mM 2-mercaptoethanol and rocked gently
for 30 min at room temperature. The gel was then
treated with 200 ml of 200 mM potassium phosphate
(pH 6.5) containing 7 mM iodoacetic acid for 10 min
at room temperature and then twice with 200 ml of 25
mM potassium phosphate (pH 6.5) for 5 min at room
temperature. After treatment as above the procedure
for transfer was essentially the same as the one de-
scribed by Southern (48) except that 25mM potassium
phosphate (pH 6.5) was used. Transfer was allowed to
proceed overnight. After the transfer the paper was
washed twice in 200 ml of water, dried in air, and
stored at 5°C until used for hybridization. For hybrid-
ization to the RNA bound to the paper the procedure
was the same as described by Alwine et al. (2). The
paper was pretreated overnight at 42°C with hybridi-
zation buffer (50% formamide, 0.75M sodium chloride,
75mM sodium citrate) containing 0.02% (wt/vol) each
of bovine serum albumin, Ficoll, and polyvinylpyroli-
done; 1.5 mg of denatured calf thymus DNA per ml,
and 1% (wt/vol) glycine. Hybridization was then per-
formed in the same mixture without the glycine and
the probe (200,000 cpm/2 ml) for 36 h at 42°C. The
paper was then washed with six to eight changes of
hybridization buffer at 37°C each for 30 min with
rocking and then with three changes of 50 mM sodium
chloride-3 mM sodium citrate at 4°C. The paper was
blotted to remove excess solution, wrapped in Saran
Wrap, and visualized by autoradiography.
RESULTS
JLS-V9 is a cell line that was derived from
BALB/c bone marrow; on infection with M-
MuLV these cells were designated JLS-V1l (58).
JLS-Vll cells were received in our laboratory at
the 18th transfer, and by the 40th transfer virus
production had dropped markedly as measured
by the amount of reverse transcriptase activity,
or particles banding at 1.16 g/cm3, in the me-
dium. We were interested to determine whether
this alteration in virus production was due to a
general decrease in virus production in all cells,
or whether it was the result of selection of virus-
negative cells present in the original JLS-Vll
culture. An infective center assay at passage 121
revealed that only 0.4% of the cells were produc-
ing M-MuLV, but the virus-positive cells pro-
duced normal quantities of virus. Therefore, it
appeared that we were dealing initially with a
heterogenous population of cells, and thus we
cloned early and late passage JLS-Vll cells.
In a clone isolated from passage 21 of JLS-
Vll cells (hereafter referred to as "Vll" cells),
all of the cells were producing virus as measured
by an infective center assay. After culture for
more than 1 year (more than 50 transfers), they
remained stable producers. From the late trans-
fer JLS-Vll cells (transfer 121), 15 clones were
isolated, all of which were negative for the pro-
duction of type C virus both by release of plaque-
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forming virus measured by XC cell assay and by
particle-associated DNA polymerase detectable
in supernatants. The cells themselves also did
not induce syncytium formation when overlaid
with XC cells. When stained with fluorescent
serum made against disrupted M-MuLV, all the
clones stained strongly positive in the cytoplasm
as well as on the cell membrane; the uninfected
JLS-V9 cells displayed no detectable fluores-
cence. It appeared therefore that the nonpro-
ducer JLS-Vll cells (hereafter referred to as
"V11-NP") expressed viral antigens but were not
able to produce any virus particles. The purpose
of the following experiments was to define the
lesion in these cells.
Proteins. The genome of retroviruses codes
for three major polyprotein gene products: (i)
Pr6Ssas, that is processed to give rise to most of
the structural proteins of the virus (5, 45); (ii)
Pr180909-P°', the precursor of p85 (reverse tran-
scriptase) (25, 27, 36); and (iii) PrSOenv, the pre-
cursor of the envelope proteins, mainly the gly-
coprotein gp7O (12, 34, 57). In characterizing
Vll-NP cells, we first determined whether any
of the viral proteins were expressed.
The quantity of p30, the major structural vir-
ion protein, and a cleavage product of Pr65sag
was measured by radioimmunoassay (Fig. 1).
V11-NP cells had no more p30 antigenic material
than uninfected V9 cells (-10 ng/mg), whereas
Vll cells producing M-MuLV and V9 cells in-
duced with bromodeoxyuridine to produce en-
dogenous MuLV (8) had high levels of p30 an-
tigen (500 to 1,500 ng/mg). In this radioimmu-
noassay, iodinated Rauscher MuLV p30 and ho-
mologous antibody made against Rauscher p30
protein were used.
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To further investigate viral protein synthesis,
polyacrylamide gel electrophoresis of specific
immunoprecipitates was used (Fig. 2). Extracts
of [35S]methionine-labeled Vll cells (slots a to
f, Fig. 2), V11-NP cells (slots g to 1), and V9 cells
(slots m to p) were analyzed with a variety of
antisera. V9 cells had no specific proteins. Vll
cells showed the array of proteins previously
characterized in other systems: Pr1809)a9POI pre-
cipitated with anti-reverse transcriptase (slot a)
and anti-p30 (slot c) and products from about
p145 to p85 precipitated only with anti-reverse
transcriptase; Pr65sas, p30, and some intermedi-
ates precipitated with anti-p30 and anti-whole
virus serum (slot e); Pr80env precipitated with
anti-gp7O (slot b) and anti-whole virus serum.
Some Pr65i'9 precipitated with the anti-reverse
transcriptase serum because a known contami-
nating activity in the serum reacts with the p15
component of Pr65as (56). Normal rabbit serum
precipitated no proteins (slot f), and p30 com-
peted out all precipitation with anti-p30 (slot d).
V11-NP cells had no detectable Pri8O9 9P" or
Pr659"9 with the same sera (slots g and i) but did
have Pr80env (slot h). The anti-whole virus serum
(slot h) precipitated a diffuse band at 70,000
molecular weight that is presumed to be the
cleaved form of glycoprotein, gp7O. Why the
anti-gp7O detected so little of this polypeptide is
not known, but this antiserum has previously
been shown to be much more avid for Pr80eMG
than for gp7O (47).
A minor component in V11-NP cells, P45, was
precipitated with anti-p30 (slot i) and anti-whole
virus serum (slot k). The reactivity with anti-
p30 was competed out with p30 (slot j). A P45
polypeptide was also evident in Vll cells ex-
232.3
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FIG. 1. p30 radioimmunoassays. Cell extracts from NP (0), JLS- V9 (A), bromodeoxyuridine-induced JLS-
V9 (U) and NP (L), and JLS- V11 (x) cells were prepared, and the radioimmunoassay was carried out as
described in the text.
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FIG. 2. Immunoprecipitation of viralproteins from Vll and VlI-NP cells. (a to f) Immunoprecipitation of
[3SJmethionine-labeled Vll cell extracts with (a) anti-reverse transcriptase serum, (b) anti-glycoprotein
serum, (c) anti-p30 serum, (d) anti-p30 serum in the presence of an excess ofpurified, p30protein, (e) rat anti-
whole virus serum, and () normal rabbit serum. (g to 1) Immunoprecipitation of[5S]methionine-labeled Vll-
NP cell extracts with (g) anti-reverse transcriptase serum, (h) anti-glycoprotein serum, (i) anti-p30 serum, (j)
anti-p30 serum in the presence of an excess ofpurified, p30 protein, (k) rat anti-whole virus serum, and (1)
normal rabbit serum. (m to p) Immunoprecipitation of[5S]methionine-labeled JLS- V9 cell extracts with (m)
anti-reverse transcriptase serum, (n) anti-glycoprotein serum, (o) anti-p30 serum, and (p) rat anti-whole virus
serum.
tracts (slots c and e). Its concentration was very
much less than that of the other p30-related
polypeptides in Vll cells, and we are uncertain
whether it derives from the M-MuLV genome or
from an endogenous or contaminating virus.
From the immunoprecipitation data, Vll-NP
cells appear to contain the glycoprotein precur-
sor as well as finished gp7O. Immunofluorescent
staining of live and acetone-fixed cells with mon-
ospecific anti-gp7O antiserum showed that the
glycoprotein was found both in the cytoplasm of
fixed cells and on the cell membrane of live cells
(unpublished data).
To investigate whether both gp70 and Pr80env
were localized on the outer cell membrane, Vll-
NP cells were radioiodinated with lactoperoxi-
dase as catalyst. Immunoprecipitation and poly-
acrylamide gel electrophoresis showed that only
labeled gp70 was precipitated with anti-gp70
(Fig. 3, lane a) even though the antiserum used
was more avid for Pr8Oenv than for gp70; neither
anti-p30 nor normal rabbit serum precipitated
any protein bands (lanes b and c). The size of
Pr8Oenv is evident from Fig. 3, lane d. When the
labeled cells were trypsinized, 70 to 80% of la-
beled gp70 was removed, indicating that most of
it is accessible to trypsinization (data not
shown). Vll-NP cells appeared to produce both
gp7O and its precursor, Pr8Oenv; only the gp70,
however, was found on the outer cellular mem-
brane.
Surface restriction. The virus-negative Vil-
NP cells were isolated from a virus-producing
culture, suggesting that the cells would be re-
sistant to superinfecting MuLV. Otherwise, V11-
NP cells should have been superinfected with
M-MuLV from producer cells in the original
JLS-V11 cultures. To clarify this point, the in-
terference properties of the Vil-NP cells were
investigated. Vl1-NP cells and control V9 cells
were infected with M-MuLV at a multiplicity of
infection of 1, and supernatants were collected
2 and 5 days after infection. Vll-NP cells pro-
duced about 1,000-fold less virus than V9 cells
(Table 1). To examine whether this strong re-
sistance to superinfection occurred at the cell
surface, the pseudotype virus, vesicular stoma-
titis virus (VSV)(M-MuLV), was produced by
infecting M-MuLV-producing cells with heat-la-
bile VSV tl-17 (7, 59). The stock was then heated
at 45°C for various times to kill VSV(VSV), and
residual pseudotypes were titered on Vll-NP
180K-
80K-
65K-
45K-
30K-
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FIG. 3. Surface iodination of gp7O on Vll-NP
cells. Surface iodination of the Vll-NP cells was
essentially carried out as described by Hynes (22).
After the iodination was stopped, the cells were
washed three times with PBS. The cell pellets were
lysed with 0.5 ml of 0.1 M Tris (pH 6.8)-2 mMphen-
ylmethylsulfonylfluoride-15% glycerol-2% SDS. Im-
munoprecipitation of the cell extracts was carried out
with (a) anti-glycoprotein serum, (b) anti-p30 serum,
(c) normal rabbit serum; (d) immunoprecipitation of
a [365]methionine-labeled Vll cell extract was car-
ried out with anti-glycoprotein serum.
TABLE 1. Interference ofNP cells with M-MuLV"
Cell Yield of XC cell (PFU/ml per 106 test cells) at:
type 2 days after infection 5 days after infection
JLS-V9 8.6 x 105 1.5 x 105
Vll-NP 1.3 x 103 1.3 x 102
a Cells (5 x 106) were plated onto 5-cm dishes, and
on the next day the cultures were infected with M-
MuLV at a multiplicity of infection of 1 in the presence
of 8 jig of polybrene per ml. After 2 h of adsorption,
the inoculum was removed, and the cells were washed
two times with regular medium. After 2 and 5 days,
24-h harvests were collected and the virus yield was
determined in an XC assay with NIH/3T3 cells as
indicators.
cells and V9 cells. Fig. 4 shows that only 10-2.5 of
VSV(M-MuLV) that could infect V9 cells was
able to infect Vll-NP cells. Therefore, Vll-NP
cells showed a marked surface restriction to-
wards M-MuLV.
Lack of pseudotype formation. To exam-
ine whether the gp7O on Vll-NP cells is able to
participate in pseudotype virion formation, the
cells were infected with VSV tl-17. M-MuLV-
producing NIH/3T3 cells were superinfected
v/v0
Minutes inactivation at 450 C
FIG. 4. Interference of NP cells with VSV(M-
MuLV). Pseudotypes of the VSV mutant tl-17 with
the coat of M-MuLV were prepared as previously
described (7) and inactivated at 45°C for the indi-
cated times. VSVplaque assays (49) were performed
with JLS-V9 (0) and NP (A) cells as indicator cells.
V/Vo is the surviving fraction after heating.
TABLE 2. Lack ofpseudotype formation between
VSV and M-MuLV in Vll-NP cellse
Surviving VSV fraction on indica-
Cells for heated tor cells:
VSV tl-17 stocks
JLS-V9 Vll-NP
M-MuLV-infected 10-3 1o-6
NIH/3T3
Vll-NP 3.5 x 10-6 1.5 x 10-6
a Subconfluent plates of NIH/3T3 cells producing
M-MuLV and Vll-NP cells were infected with VSV
tl-17 at 32°C at a multiplicity of infection of 1 to 2.
The virus was absorbed in a volume of 0.5 ml/5-cm
dish. After 45 min of adsorption, the inoculum was
removed, the cells were washed once with regular
medium, and then 5 ml of regular medium was added.
After 12 h of infection at 320C, the virus yield was
harvested, and portions were heat inactivated at 45°C
for 60 min. The residual fraction of VSV was then
determined in a VSV plaque assay on JLS-V9 and
Vll-NP cells at 320C.
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with VSV tl-17 in parallel, and the two VSV
stocks were then heated at 45°C to eliminate the
pure VSV in the populations. To detect pseu-
dotypes, the stocks were assayed on V9 cells or
Vll-NP cells (Table 2). Although the stock
grown on the M-MuLV-infected cells had 103
PFU of pseudotype VSV per ml that appeared
on V9 cells but not Vll-NP cells, no such pseu-
dotypes were evident in the VSV preparation
made on V11-NP cells. The gp7O on the surface
of Vll-NP cells thus appears incapable of par-
ticipating in pseudotype virion synthesis.
Expression of M-MuLV-specific RNA in
producer and nonproducer cells. The M-
MuLV-specific RNA in Vll-NP cells was ex-
amined to determine whether the lack of viral
proteins in the nonproducer cells was due to an
alteration in the expression of virus-specific
RNA. Cytoplasmic RNA extracted from pro-
ducer and nonproducer cells was annealed with
M-MuLV cDNA in conditions of virus-specific
RNA excess (13). At saturation, RNA from the
Vll-NP cells could anneal M-MuLV cDNA to
the same (maximal) extent as RNA from the
producer cells (Fig. 5), indicating that essentially
all virus-specific RNA sequences that could be
recognized by the M-MuLV cDNA probe were
present in the nonproducer cells. In annealing
experiments performed in this manner, the vi-
rus-specific RNA concentration is inversely pro-
portional to the product of RNA concentration
and annealing time that gives half-maximal an-
nealing (the Crtl/2 value) (13). Comparison with
the Crtl/2 value for pure M-MuLV 70S RNA
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FIG. 5. Annealing of cytoplasmic RNAs with M-
MuLV-specific cDNA. Cytoplasmic RNA extracted
from producer and non-producer JLS- VlI cells was
annealed with 3H-labeled M-MuLV-specific cDNA
for different lengths of time. The percent maximal
cDNA hybridized is plotted as a function of the C,t
value (product of RNA concentration and time of
annealing) corrected to standard conditions (10). The
Crtii2 values are also indicated. Symbols: 0, producer
JLS- Vl I cell RNA; 0, nonproducer cell RNA.
(4.02 x 1o-2 mol-s/liter at standard annealing
conditions [15]) indicated that 0.03% of the cy-
toplasmic RNA from Vll-NP cells and 0.10% of
the producer cell cytoplasmic RNA was virus
specific. The lack of virus production in the
nonproducer cells, therefore, did not result from
marked alteration in the expression of virus-
specific RNA because no change in extent of M-
MuLV-specific sequences present was detected
and the concentration of these sequences was
only threefold lower than for producer cells.
Uninfected BALB/c mouse cells contain RNA
sequences that can anneal with M-MuLV cDN
to a limited extent (6, 8, 14, It; at least some of
tnese seuences may represent endogenous C-
type irsesTo ensure that t
Fig. 5 were analyzing transcription of M-MuLV
cDNA and not uninfected cell sequences, pro-
ducer and nonproducer cell RNAs were an-
nealed with M-MuLV cDNA that had been de-
pleted of sequences that anneal with uninfected
BALB/c cell DNA (a kind gift of Rudolf Jae-
nisch). V11-NP and Vll cell RNA annealed to
equal extents to the selected cDNA probe (Fig.
6). The CrtI/2 values indicated that with these
RNA preparations, the nonproducer cell cyto-
plasmic RNA contained approximately one-
fourth as much virus-specific RNA as producer
cells (0.06 versus 0.26%).
Intracellular virus-specific RNA in cells pro-
ducing MuLV consists of 38S and 21S virus-
specific RNA (11, 13, 33, 43, 54). To examine
whether the same virus-specific RNA species
were present in the nonproducer cells, cytoplas-
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FIG. 6. Annealing of cytoplasmic RNAs with se-
lected M-MuLV-specific cDNA. Cytoplasmic RNA
from producer and nonproducer JLS-VII cells (dif-
ferent preparations from Fig. 5) was annealed with
M-MuLV cDNA which had been depleted ofBALBI
c uninfected cell sequences. Analysis was the same as
in Fig. 5. Symbols: 0, producer JLS-VII cell RNA;
0, nonproducer RNA.
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FIG. 7. Electrophoretic analyses of cytoplasmic
RNA from VII-NP cells. A 5-tLg amount each of
polyadenylic acid-selected cytoplasmic RNA from
Vll-NP cells, Vll producer cells, and uninfected
JLS- V9 cells was electrophoretically separated on a
1% agarose methylmercuric hydroxide gel for 2.5 h at
6 V/cm. The RNA in the gel was then transferred to
diazobenzyloxymethyl paper, and the M-MuLV spe-
cific bands were visualized by hybridization with 32P-
labeled M-MuLV cDNA. The exposure time for the
autoradiography was 8 h. (a) Pure M-MuLV RNA;
(b) VII-NP RNA; (c) Vl producer RNA; (d) JLS- V9
RNA.
mic RNA extracted from Vll-NP was separated
by electrophoresis through denaturing methyl-
mercuric hydroxide agarose gels. The RNA was
transferred from the agarose gel to diazoben-
zyloxymethyl paper, an affinity paper for nucleic
acids described by Alwine et al. (2). The virus-
specific RNAs covalently linked to the paper
were then detected by hybridization with P-
labeled M-MuLV cDNA. The largest viral RNA
in the Vll-NP cells (Fig. 7, lane b) was 1,000
nucleotides shorter than that of wild-type M-
MuLV RNA (Fig. 7, lane a); the subgenomic 21S
RNA was present in both the M-MuLV-produc-
ing cells (Fig. 7, lane c) and the Vll-NP and was
apparently the same size in the two cell lines.
Vll producer cells contained the regular ge-
nomic 38S RNA, subgenomic 21S RNA, and an
RNA that comigrated with the larger virus-spe-
cific RNA of the Vii-NP cells (Fig. 7, lane c).
Uninfected cells showed no RNA bands by this
procedure (Fig. 7, lane d).
The Vll-NP cells therefore appear to contain
a genome having a 1,000-nucleotide deletion.
The deletion, though, does not affect the size of
the 21S subgenomic RNA, implying that the
deletion occurs outside of the regions covered by
this RNA. The inability to detect the deletion
by liquid hybridization experiments (Fig. 5 and
6) is probably a consequence of its representing
only 11% of the 9,000-nucleotide genome. The
Vll producer cells contained both full-length
38S RNA as well as a species with most likely
the same deletion as the one found in the Vll-
NP cells. Virus produced by the Vll cells also
contains full-length 38S RNA and the deleted
molecule (P. Besmer, unpublished data).
To determine whether the deleted genomic
RNA as well as the 21S subgenomic RNA was
contained in polyribosomes, the polyribosome
fraction of the Vii and V11-NP cells was treated
with or without EDTA and analyzed by sedi-
mentation through sucrose gradients. Virus-spe-
cific RNA in the "released messenger region" of
the sucrose gradients (50 to 200S) was further
analyzed by sedimentation through sucrose-
SDS gradients, and virus-specific RNA appear-
ing in this region after EDTA disruption of
polyribosomes was scored as functional mRNA.
(15). By this criterion polyribosomes from the
Vll-NP and the Vii cells contained both ge-
nome size 35 to 38S and subgenomic 21S
mRNA's (Fig. 8). The deleted genome RNA
from the Vll-NP cells is therefore found on
polyribosomes as well as the subgenomic 21S
RNA.
Can the virus genome in the V11-NP cells
be rescued? Previously we have shown that
uninfected V9 cells can be induced to produce
the BALB/c endogenous xenotropic (MuLVx)
and ecotropic (MuLVE) virus upon treatment
with halogenated pyrimidines (8). The N-tropic
MuLV does not form XC cell plaques when
assayed in an XC assay with NIH/3T3 cells as
indicators (50). Vll-NP cells were treated with
bromodeoxyuridine to determine whether the
compound could induce the endogenous V9 vi-
ruses, which might then rescue or complement
the M-MuLV contained in the Vii-NP cells.
The virus yield 2 days after removal of the
halogenated pyrimidine was determined (Table
3). V9 cells upon induction produced 3 x 105
focus-forming units of MuLVx per ml (as meas-
ured by a focus assay on S+L- cat cells) and no
XC cell plaques on NIH cells. The Vii-NP cells
upon induction produced 3 x 105 focus-forming
units of MuLVx per ml but also made 50 to 100
PFU of virus per ml that gave XC cell plaques
on NIH cells. In an attempt to separate this low
amount of XC plaque-forming virus from the
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FIG. 8. Size of M-MuLV-specific mRNA in JLS-VI1 and Vll-NP cells. (a) JLS-Vll cells. Purified
polyribosomes were prepared from 1015-cm tissue culture dishes ofJLS-V1I cells at half confluency. Before
extraction the cells had been treated with 1 pg of cycloheximide per ml for 30 min to increase the size of the
polyribosomes. The polyribosomes were divided in half, and one half was treated with 10 mm EDTA to
disaggregate them. The two samples were thein sedimented in a sucrose gradient to display thepolyribosomes
(not shown), and fractions containing the "rekased messenger" regions (50 to 200S) were pooled. RNA was
extracted from the two pooled samples and sedimented in a 10.5-ml 15 to 30% sucrose gradient in SDS buffer
containing 0.1% SDS. After centrifugation in a Beckman SW41 rotor for 12 h at 24,000 rpm and 25°C, the
gradients were fractionated, and 100-pl portions of each fraction were concentrated by ethanol precipitation
into 50 IlI of 0.3 M NETES-0.1% SDS buffer. 3H-labeled M-MuLV cDNA (550 cpm) was added to each
concentrated fraction and annealing was performed at 66°C for 18 h. After annealing, the samples were
digested with Sl nuclease, and the amount ofSl-resistant radioactivity was determined. The relative amount
of virus-specific RNA present in each fraction was calculated from the percentage of cDNA hybridized as
before (a relative virus-specific RNA concentration of corresponds to 50% cDNA probe annealed) (13). The
data from the two sucrose gradients are superimposed, and the locations of the 28S and 18S rRNA's
(determined by monitoring the sucrose gradient for absorbance at 260 nm during fractionation) are also
indicated. Symbols: 0, data from the EDTA treated polyribosomes; 0, data from the control polyribosomes.
(b) Vll-NP cells. A similar experiment wasperformed with 1015-cm dishes of Vll-NP cells at half-confluency.
TABLE 3. Rescue ofM-MuLV from Vll-NP cells
upon induction with bromodeoxyuridinea
Cells XC plaques/ml MuLVx(FFU/ml)
JLS-V9 0 3 x 105
V11-NP 50-100 3 x 105
a Bromodeoxyuridine induction ofVl1-NP cells was
performed as described previously (8). Two days after
the removal of the bromodeoxyuridine-containing me-
dium from the cultures, a 24-h harvest was collected,
and the XC plaque titer on NIH/3T3 indicator cells
and MuLVx titer on cat S+L- cells were determined.
FFU, Focus-forming units.
endogenous non-plaque-forming N-tropic virus,
5 x 10i NIH cells were infected with the induced
virus from NP cells. At 5 days after the infection,
the supernatant was used to infect a new culture
of NIH cells, and this procedure was repeated
three times. A virus stock was then prepared
and titered on NIH and BALB/c cells. Two
independent virus isolates derived were N-tropic
and XC plaque-forming viruses and not NB-
TABLE 4. Characterization of virus isolated from
the bromodeoxyuridine-induced virus of Vll-NP
cellsa
Virus titer on:
Isolate NIH cells BALB/c 3T3 cells
(XC plaques/ml) (XC plaques/ml)
1 2.6 x 105 6 x 103
2 4.3 x 105 6 x 103
a NIH/3T3 cells were plated at 5 x 105 cells per 5-
cm dish, and on the next day the cultures were infected
with bromodeoxyuridine-induced virus from Vll-NP
cells in the presence of 8 jg of polybrene per ml. At 5
days after infection, a 24-h harvest was used to infect
a new culture of NIH/3T3 cells, and this procedure
was repeated three times. From the third infected
culture, 5 days after the initial infection a 24-h harvest
was collected. The respective XC plaque titers ofthese
isolates were then determined on NIH/3T3 cells and
on BALB/c 3T3 cells.
tropic as would be expected forM-MuLV (Table
4). These N-tropic viruses thus have the host
range marker of the endogenous BALB/c N-
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tropic virus (30, 40) and the large XC plaque
morphology marker ofM-MuLV (44). They may
be recombinants between the endogenous N-
tropic MuLV and the defective M-MuLV in Vll-
NP cells. Recombinants involving the Fv-1 host
range marker and the XC plaque morphology
marker have been described previously (21).
DISCUSSION
Origin of V11-NP cells. The V11-NP cell
line appears to have arisen from infection by a
deletion mutant of M-MuLV. This deletion
probably existed in the stock M-MuLV used to
infect JLS-V9 cells and generate the parental
JLS-Vll cell culture. Both the stable producer
Vll clone studied here and the V11-NP clone
contained this M-MuLV RNA lacking 1,000 nu-
cleotides; the producer also had full-size M-
MuLV RNA. If Vll-NP had been derived as a
mutant from Vll, then the deleted RNA would
probably not have been found in the producer
cells.
The Vll producer cells, once cloned, have
been stable producets for more than 100 gener-
ations thereafter. Thus, there is no tendency to
lose the nondeleted genome, and we conclude
that the V11-NP cells probably did not ever
have a nondeleted genome. The Vll-NP cells
appear to have a slight growth advantage such
that they could overgrow the producer cells in
the original mixed culture, and they are resistant
to superinfection by M-MuLV. These two prop-
erties most likely were essential for the isolation
of the Vl1-NP cells.
Nature and consequences of the deletion
in Vll-NP cells. The Vll-NP cells have both
deleted genome-size RNA (vRNA) and normal-
size 21S RNA on polyribosomes. They express
env normally, making an intracellular Pr8O that
cleaves to a surface gp70. Thus, the 21S RNA,
known to be the glycoprotein mRNA (54), ap-
pears to be unchanged in structure and function
by the deletion. By contrast, no Pr659'9 or
Pr1809'"" is evident in the cells, implying that
the deletion has interferred with their expres-
sion. RNA indistinguishable from vRNA is
known to be themRNA for the gag-pol products
(27, 33, 54). The P45 protein in the Vl1-NP cells
could be the product of the mRNA function of
the deleted vRNA in the polyribosomes. If this
protein is the N-terminal fragment ofthe nornal
gag polypeptide, it should have p15, p12, and
some of p30. The deletion may therefore occur
within the p30 gene. We are presently analyzing
P45 further, but it is worth noting that this
fragment is just the size of the gag fragment
found in the product of the Abelson MuLV
genome (56). In both Vl1-NP and Abelson
MuLV-infected cells, the product is immunopre-
cipitated by anti-p30 antiserum but does not
register in radioimmunoassays (37). Thus, the
deletion mutant described here either could be
the parent of Abelson MuLV or could represent
a site at which deletions or substitutions fre-
quently occur. The virus in Vll-NP cells might
even have a partially substituted genome.
An implication from this analysis is that the
splicing event that makes the 21S mRNA can
occur even though the intervening region has
been partly deleted. This conclusion is subject,
however, to the reservation that different inte-
grated viral genomes may give rise to the vRNA
and to 21S mRNA in Vll-NP cells.
Lack of VSV pseudotype production by
Vll-NP cells. Although Vll-NP cells have
gp7O on their surface, numerous attempts to
produce VSV psuedotypes in these cells have
failed (Table 2). This result supports an earlier
conjecture (55) that to have a glycoprotein in-
corporated into the envelope of a virus requires
both the glycoprotein and a submembrane pro-
tein. The lack of the submembrane Pr65Vg in
V11-NP cells presumably prevents gp7O from
participating in pseudotype formation.
Mutability ofthe M-MuLV genome. In pre-
vious work (20, 35, 41, 42, 47), we and others
have characterized five nonconditional mutant
classes of MuLV's that are phenotypically dif-
ferent from the deletion in V11-NP (see refer-
ence 47). These other mutants arose from care-
fully cloned MuLV's in one passage, implying a
very high rate of spontaneous mutations during
MuLV passage. At least one of the five classes
represented a deletion mutant. That deletion
(M23) abolished both pol and env function but
leftgag function intact (47). The ability to derive
cell lines with a range of M-MuLV mutants
should facilitate analysis of the roles of the var-
ious gene products in the life of the virus. The
high rate of generation of mutants, however,
must be considered in any explanations of the
behavior retrovirus-infected cells.
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